Bone Health
  • 30 Nov 2023
  • 1 Minute to read
  • PDF

Bone Health

  • PDF

Article summary

  • HRT has been shown to have an effective role in the prevention and treatment of osteoporosis.
  • Studies have shown a bone-preserving effect even with relatively low doses of oestrogen replacement.
  • The bone-protective effect of oestrogen is dose and duration related, and the bone preserving effect of HRT declines after discontinuation of treatment.
  • NICE says the risk of fragility fracture is decreased while taking HRT and this benefit is maintained during treatment but decreases once treatment stops.

  • HRT should be considered the first-line therapeutic intervention for the prevention and treatment of osteoporosis in women with premature ovarian insufficiency (POI).
  • Bisphosphonates are considered as first-line options for most patients with postmenopausal osteoporosis due to their broad spectrum of anti-fracture efficacy. HRT may be considered as an additional alternative option, particularly in younger postmenopausal women with menopausal symptoms, who are at increased risk of fractures.
References and Further Information:

Was this article helpful?